[Medicine heaven and earth] many unapproved drugs have been "chased by the market"; Hongmao returns to the field of vision, and many TV channels are advertising; the exaggerated publicity of Tianqing shares is concerned; pharmacy trusteeship encounters "crisis"

The Bureau of life and death of local dynamic consistency evaluation has been opened, and many non evaluated drugs have been known as "city by city" Before that, Jiangxi, Guangxi and Heilongjiang have announced the suspension of the network qualification of non evaluated drugs, with a total of 45 drug regulations On November 22, Jiangsu public resources trading center suspended the online purchase of nine drugs that failed to pass the consistency evaluation, including nine enterprises including Sinopharm Rongsheng pharmaceutical, lunanbete pharmaceutical, Guangzhou Baiyunshan, etc Drugs that have not been evaluated can be described as "coming winter" Guangdong, Liaoning, Hunan, Jiangxi, Zhejiang, Heilongjiang and other 14 provinces hold the attitude of not purchasing products without evaluation And Jiangsu Province issued a document in early November, stipulating to cancel the approval document for generic drugs that failed to pass the consistency evaluation, and to intensify efforts to eliminate products with low quality, high repetition rate and failed to pass the consistency evaluation At the same time, the drugs that have not been evaluated may also lose 11 cities On November 21, Shanghai Sunshine pharmaceutical purchasing website released "4 + 7 supplementary documents for centralized purchasing of urban drugs in Shanghai", which indicated that those products that failed to pass the consistency evaluation had the opportunity to continue to purchase and use, but the price would certainly be lower than those of the winning products (i.e 30% - 40% of the remaining markets would also be subject to price reduction, and generic drugs that failed to pass the evaluation must be at a low price); for the same varieties, 3 If the family consistency evaluation is full, the failed varieties will not be purchased at all Guangdong checked more than 2000 drugs, and stipulated that enterprises with fraud behaviors were not allowed to enter the market for trading for two years On November 20, Guangdong Drug Delivery Center issued two price lists, one of which was the drugs whose difference between the lowest price and the highest price was more than three times, totaling 1809; the other was the drugs whose price was in doubt, totaling 332 Among them, Guangdong drug delivery center requires relevant enterprises to clarify the drugs whose price information is doubted to be under reported, misreported or other problems within the specified time The drug-related enterprises with large price gap need to check the price If the drug-related enterprises fail to comply with the requirements within the time limit, and find that the enterprises do have fraud such as false report, concealment, false report, and missing report, once verified, the serious ones will be disqualified from entering the market for trading within two years in Guangdong Province On November 21, the Shenzhen Municipal Bureau of human resources and social security released the announcement on the evaluation results of 2018 supplementary selection experts This medical insurance catalogue covers 10 kinds of heavy-duty anticancer drugs, such as ansanza (aletinib hydrochloride capsule), coreda (pabolizumab injection), Lipitor (olapari tablets), among which coreda has entered the urban medical insurance catalogue for the first time At the same time, Shenzhen continues to supplement and improve the medical insurance for major diseases, greatly reducing the burden of patients' medical expenses On November 23, the official website of the Ministry of Commerce issued the guidance on classified and classified management of national retail pharmacies (Draft for comments) It is clearly stipulated that by 2020, the classification and classification management system of retail pharmacies in most provinces and cities will be basically established; by 2025, the unified classification and classification management system of retail pharmacies nationwide will be basically established This policy directly divides the retail drugstores into three categories according to the operating conditions and compliance status, and the scope of operation of different types of drugstores is also different, for example, the first type of drugstores can operate class B over-the-counter drugs; the second type of drugstores can operate over-the-counter drugs, prescription drugs (excluding prohibited and restricted drugs), Chinese herbal pieces, etc In the past, Beijing, Guangdong, Yunnan and other places have successively implemented classified and hierarchical management of the operating conditions, service capacity and risk status of retail pharmacies At the same time that the above-mentioned "opinion draft" was published, some people in the industry believed that the policy would benefit chain drugstores (such as medical insurance and prescription outflow), and the market space of single drugstores would be further squeezed In recent years, pharmacy trusteeship has become more and more popular, sweeping a large number of secondary and lower hospitals However, the disadvantages of its mode are increasingly prominent, such as exclusive distribution, monopoly operation, and medical support by medicine This has attracted the attention of local regulatory authorities A large number of trusteeship pharmacies with problems have been stopped and rectified In early October, Sichuan provincial authorities said Xichong County was stopped and rectified for trusteeship and drug distribution in public hospital pharmacy due to suspected monopoly; In June, Shanghai Health and Family Planning Commission issued a document, which pointed out that "in the process of optimizing the supply chain of pharmacies, public medical institutions should carefully set up the cooperation mode with pharmaceutical enterprises, and should not carry out" trusteeship "or similar business cooperation with relevant enterprises, so as to prevent possible legal and policy risks brought by cooperation." Hubei Provincial Health and Family Planning Commission said at the fourteenth "Pro Qing" political and business forum of Chu merchants that it is not allowed for pharmacies to be entrusted in Hubei Province; Liaoning Province prohibits any form of interest conversion and interest transfer in disguised form of pharmacy trusteeship to maintain medicine; On May 21, the Beijing Municipal Bureau of Medical Administration issued a new regulation, which states that when doctors prescribe purchased drugs for patients, they shall not designate patients to go to specific pharmacies, pharmacies (including hospital self funded pharmacies, self run pharmacies) or other medical institutions for purchase; In December last year, the Shandong provincial government issued a document saying that it would "improve the management measures of drug distribution enterprises, strengthen the supervision of drug distribution behavior, prevent exclusive distribution and monopoly operation, and prohibit offline purchase and distribution of drugs." Zeng issued a document by Guangdong Development and Reform Commission, which made it clear that the government or the competent authorities of the industry could not illegally designate the provision of services, exclude and restrict the fair competition of industry enterprises, and could not deprive the legal pricing rights of market competitors of 10 forms of abuse of administrative power; the people's Hospital of Anyi County, Nanchang, Jiangxi Province, and the hospital of traditional Chinese medicine entrusted the pharmacy to a third-party pharmaceutical enterprise without public bidding After the local health and Family Planning Commission intervened in the investigation, the custody of the pharmacy has been stopped; as early as 2016, the health and Family Planning Commission of Qinghai Province issued a document requiring "no medical institutions to carry out custody or contracting of the pharmacy" The attitude of local governments towards the trusteeship of pharmacies is quite clear, that is to say, it is strictly forbidden to produce the trusteeship of pharmacies where the interests are transferred or transferred in a disguised way to support the doctors with drugs For pharmaceutical companies, another main body of pharmacy trusteeship, optimism is not the same as before It is reported that step pharmaceutical and kyushutong have jointly adjusted the pharmacy custody business model to a professional pharmacy business model; relevant persons of Sinopharm have said that the company has carried out pharmacy custody business in the past, but now "does not make money, and there are policy risks", which has not been done Some in the industry also said that once the outflow of prescriptions was "opened", the custody of pharmacies might be further tightened More than ten TV channels of local hot news reappear Hongmao's figure and start a new round of "harvest season" According to hexun.com, since late October, more than ten TV channels have reproduced Hongmao medicine and wine, mainly including ground TV stations and third-line TV stations, such as Yunnan TV station, Guangdong Southern TV station, Liaoning TV Station City channel, Harbin TV station, Tianjin TV station and other local channels Short films of different lengths, corner markers in the lower right corner, and the title logo of TV programs The four words "Hongmao medicine wine" and the advertisement language are full of the advertisement time and the program positive film of these channels In addition, the article also mentioned that Hongmao ranked first in the review report of the advertising market in the first three quarters of 2018, and such products are mainly targeted at provincial satellite TV and provincial ground stations Propagandize "cure all diseases"! Recently, the company's "operation" has been a miracle According to the media, Tianqing Co., Ltd (832035, OC), a company listed on the new third board of stem cell storage application in Harbin, Heilongjiang Province, declared: "here, we are realizing our millennium dream." And the company's Affiliated Hospital Publicity Department treats rheumatoid arthritis, lupus erythematosus, all kinds of diabetes and complications, Parkinson's disease and other diseases, even infertility, male erectile dysfunction (ED) and other diseases However, it is said that the price of stem cell treatment service is not cheap A course of treatment requires four stem cell reinfusion, and the lowest price is 60000 yuan At the same time, the company also publicized on its website that it had formed a research and development alliance with first-class domestic universities, including Shanghai Tongji University Medical College, the Fourth Affiliated Hospital of Harbin Medical University, etc However, after further visit and understanding by the reporter, they all received the negative reply from the above hospitals Subsequently, the reporter reported the situation to the Heilongjiang Provincial Health and Health Commission Relevant personnel said that at present, only the first and second affiliated hospitals of Harbin Medical University carry out stem cell clinical research in Heilongjiang, and stipulated that the research can not be charged Information source: Pharmaceutical intelligence elite club, daily economic news, pharmaceutical cloud studio, cypress blue, bureau of health and information, Hexun and other statements: this point of view only represents the author, not the position of pharmaceutical intelligence network, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.